Newsfeeds Archive - Spark Newswire

1 minute read

Jaguar Health To Present Phase 3 OnTarget Trial Results For Its Cancer Supportive Care Drug Crofelemer On Or Before July 23, 2024

June 12, 8:38 AM

Investor webcast on or before July 23 will include updates on Jaguar's cancer supportive care portfolio, including participation from Jaguar scientific team, patient advocates, and leading oncology experts on cancer

JAGX

1 minute read

Movers

12 Health Care Stocks Moving In Thursday’s Pre-Market Session

By Benzinga Insights

May 30, 8:07 AM

Gainers Cue Health (NASDAQ:HLTH) stock moved upwards by 44.2% to $0.08 during Thursday’s pre-market session. The market value…

BSGM

2 minute read

Movers
News

What’s Going On With Jaguar Health Stock?

By Erica Kollmann

May 23, 12:23 PM

Jaguar Health shares are falling after the stock effected a reverse split at an exchange ratio of 1-for-60 Thursday, in order to support the company's compliance with Nasdaq listing standards.

JAGX

3 minute read

Dow Falls Over 150 Points; Sohu Posts Q1 Loss

By Avi Kapoor

May 20, 2:31 PM

U.S. stocks traded mixed toward the end of trading, with the Dow Jones index falling more than 150…

AKTS

4 minute read

Why Virios Therapeutics Shares Are Trading Lower By Around 48%? Here Are Other Stocks Moving In Monday’s Mid-Day Session

By Avi Kapoor

May 20, 1:28 PM

Shares of Virios Therapeutics, Inc. (NASDAQ:VIRI) fell sharply during Monday’s session after the company priced a $1.7 million…

AKAN

2 minute read

Movers

12 Health Care Stocks Moving In Monday’s Intraday Session

By Benzinga Insights

May 20, 12:31 PM

Gainers GT Biopharma (NASDAQ:GTBP) shares rose 173.5% to $8.53 during Monday’s regular session. The market value of their…

AIH

2 minute read

Why Jaguar Health Stock Is Tanking

By Erica Kollmann

May 20, 12:13 PM

Jaguar Health shares are falling Monday after the company announced a 1-for-60 reverse stock split. The company will effect a reverse stock split at an exchange ratio of 1-for-60, on Thursday, in order to support the company's compliance with Nasdaq's listing standards.

JAGX